Literature DB >> 31317771

Amino Acid Prevalence of HIV-1 pol Mutations by Direct Polymerase Chain Reaction and Single Genome Sequencing.

Philip L Tzou1, Soo-Yon Rhee1, Robert W Shafer1.   

Abstract

The presence of many highly unusual HIV-1 mutations at a minority variant threshold by next-generation sequence (NGS) may indicate that a high proportion of variants at or just above the threshold represent PCR errors. The validity of this hypothesis depends on the concept that highly unusual mutations detected by population-based sequencing are also highly unusual within a person's virus population. Highly unusual mutations were defined as mutations with a prevalence <0.01% in group M HIV-1 direct PCR population-based Sanger sequences in the Stanford HIV Drug Resistance Database. Single genome Sanger sequences [single genome sequences (SGSs)] were analyzed because they are not subject to PCR error. Permutation analyses compared the proportion of highly unusual mutations in SGSs with the empirical frequencies of these mutations in repeated random selections of population-based sequences. We created a database of 11,258 pol SGSs in 963 plasma samples from 345 persons with active virus replication and analyzed the subset of samples containing 10 or more SGSs. Highly unusual mutations occurred more commonly in samples undergoing SGS compared with population-based sequencing in protease (3.9% vs. 0.8%; p < .001), reverse transcriptase (6.5% vs. 1.5%; p < .001), and integrase (5.0% vs. 1.8%; p < .001). Highly unusual mutations occur more commonly in SGSs than in population-based sequences. However, they comprise a small proportion of all SGS mutations supporting the concept that the presence of many highly unusual mutations just above an NGS threshold suggests that the threshold is too low.

Entities:  

Keywords:  HIV-1 pol; PCR; mutation; next-generation sequencing; single genome sequencing

Year:  2019        PMID: 31317771      PMCID: PMC6806363          DOI: 10.1089/AID.2018.0289

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

Authors:  Sara Gianella; Wayne Delport; Mary E Pacold; Jason A Young; Jun Yong Choi; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.

Authors:  Cassandra B Jabara; Corbin D Jones; Jeffrey Roach; Jeffrey A Anderson; Ronald Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

3.  MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.

Authors:  Michael Huber; Karin J Metzner; Fabienne D Geissberger; Cyril Shah; Christine Leemann; Thomas Klimkait; Jürg Böni; Alexandra Trkola; Osvaldo Zagordi
Journal:  J Virol Methods       Date:  2016-11-17       Impact factor: 2.014

4.  Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing.

Authors:  Philip L Tzou; Pramila Ariyaratne; Vici Varghese; Charlie Lee; Elian Rakhmanaliev; Carolin Villy; Meiqi Yee; Kevin Tan; Gerd Michel; Benjamin A Pinsky; Robert W Shafer
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

5.  Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.

Authors:  Justin R Bailey; Ahmad R Sedaghat; Tara Kieffer; Timothy Brennan; Patricia K Lee; Megan Wind-Rotolo; Christine M Haggerty; Ashrit R Kamireddi; Yi Liu; Jessica Lee; Deborah Persaud; Joel E Gallant; Joseph Cofrancesco; Thomas C Quinn; Claus O Wilke; Stuart C Ray; Janet D Siliciano; Richard E Nettles; Robert F Siliciano
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  HIV populations are large and accumulate high genetic diversity in a nonlinear fashion.

Authors:  Frank Maldarelli; Mary Kearney; Sarah Palmer; Robert Stephens; JoAnn Mican; Michael A Polis; Richard T Davey; Joseph Kovacs; Wei Shao; Diane Rock-Kress; Julia A Metcalf; Catherine Rehm; Sarah E Greer; Daniel L Lucey; Kristen Danley; Harvey Alter; John W Mellors; John M Coffin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

Authors:  M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

8.  Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.

Authors:  Marc Noguera-Julian; Dianna Edgil; P Richard Harrigan; Paul Sandstrom; Catherine Godfrey; Roger Paredes
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 5.226

9.  Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.

Authors:  Marta E Bull; Caroline Mitchell; Jaime Soria; Sheila Styrchak; Corey Williams-Wietzikoski; Jillian Legard; Jennifer McKernan-Mullin; Kelli Kraft; Frankline Onchiri; Joshua Stern; Sarah Holte; Kevin J Ryan; Edward P Acosta; Alberto La Rosa; Robert W Coombs; Eduardo Ticona; Lisa M Frenkel
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

10.  Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.

Authors:  Farbod Babrzadeh; Vici Varghese; Mary Pacold; Tommy F Liu; Pål Nyrén; Celia Schiffer; W Jeffrey Fessel; Robert W Shafer
Journal:  J Antimicrob Chemother       Date:  2012-10-19       Impact factor: 5.790

View more
  1 in total

1.  Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.

Authors:  Philip L Tzou; Sergei L Kosakovsky Pond; Santiago Avila-Rios; Susan P Holmes; Rami Kantor; Robert W Shafer
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.